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                                   ABSTRACT 
 
BACKGROUND: 
     Most   of  the  patients  having  chronic peptic ulcer disease  are  
usually  found  to  be  infected with  helicobacter pylori  infection. 
Previously, when  the  ulcer  goes  for  perforation, immediate acid-
reduction surgery  was  being  done, as  there  was  a  high incidence  of  
relapse  of  ulcers  after  a  simple  closure.  But,  since  most  of  the  
ulcers  are  caused  by  H. pylori,  eradication  of  these  organisms  
reduces  the  recurrence  of  ulcers .  The  aim  of  our  study  was  to  
study  the  incidence  of  Helicobacter pylori  in  cases  of  duodenal  
ulcer  perforation.   
METHODS: 
Our  study  included  30  operated  patients  of  duodenal  ulcer  
perforation  and  the  incidence  of  H. pylori  was  found  from  the   
biopsy  taken  from  ulcer  edge,  using   Rapid  urease  test  &  HPE. 
RESULTS: 
Among  thirty  patients,  samples  of   16  patients (53.3%)  showed  
Positive  for  Helicobacter pylori  in  Rapid urease test (CLO TEST)  and  
HPE.  The  p value  calculated  is < 0.05  which  is  found  to  be  
significant  by  chi square  test. 
 CONCLUSION: 
As  Helicobacter pylori  is  the  most  common  cause  for  
duodenal  ulcer  perforation,  anti-helicobacter pylori  eradication  
regimen  can  be  used  in  all  cases  of  perforated  duodenal ulcer  to  
prevent  the  ulcer  recurrence and  to  prevent  acid  reducing  surgeries 
 
 
 
  
TABLE  OF  CONTENTS 
 
SI NO TITLE PAGE 
1. INTRODUCTION 1 
         2. AIM AND OBJECTIVE 3 
3. REVIEW  OF LITERATURE 4 
4. MATERIALS  AND  
METHODS 
43 
5. RESULTS  AND  
OBSERVATIONS 
69 
6. DISCUSSION 83 
7. CONCLUSION 86 
8. BIBILIOGRAPHY 88 
9. ANNEXURES 
1) PROFORMA 
2) CONSENT FORM 
3) MASTER CHART 
 
 
  
1 
 
INTRODUCTION 
Previously,  the  researches  done on  ‘Duodenal  ulcer’ mainly 
concentrated  on  the  abnormalities  in  the  secretion  of  acids.  Most  of  
the  researches    found  that  all  duodenal  ulcer  patients  have  raised  
maximal  acid  output  (MAO),  in  response  to  histamine  or  
pentagastrin,  showing  a  greater  parietal  cell  mass  (Blair  and  others  
1987).  Also,  the  acid  secretion  physiology  is  abnormal.  Basal  acid  
is  raised  to  greater  extend, which  is  identified  from  the  increase  in  
MAO. 
Researches  done  on  hormonal  control  mainly  concentrated  on  
Gastrin, an  antral  acid  stimulating  hormone. Research  showed  that  
gastric  acid  inhibition  by  intra gastric  acid  is  decreased  in  the  
duodenal  ulcer  patients  (Calam & Moss 1992).  An  important  mediator  
named  somatostatin  inhibits  gastric  acid,  also  inhibits immune  
reactive  somatostatin  cells.     In  patients  with  duodenal  ulcer,  
amount  of  somatostatin  peptide  present  in  gastric  antral  mucosa  are  
reduced  (Mc  Henry  Jr  et  al  1993). 
Normally,   the  gastrin  release  is  inhibited  by  intragastric  acid.  
This  mechanism  is  altered  in  patients  infected  with  Helicobacter 
pylori  causing  Duodenal  ulcer. 
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 Eradication  of   H.pylori  from  duodenal  ulcer  patients  increases 
somatostatin  RNA  by  about  two  folds  in  antral  and  duodenal  
mucosa,  but  not  in  corpus  biopsies,  this  reflects  typical  distribution  
of   involvement  of  mucosa  in  patients  with  duodenal  ulcer (Sipponen  
1992).8 
 The  realization  that  Helicobacter Pylori  may  have  a  
fundamental   role  in  the  etiology  &  the  pathogenesis  of  peptic  ulcer  
has  lead  to  therapeautic  strategies  aimed  at  eradicating  this  
bacterium  and  curing  the  disease. 
 Perforated  peptic   ulcer  is  approximately  7  to  10  cases  per  
100000  population  per  year.  Perforation  is  present  in  about  7%  of  
patients  were  admitted  in  hospital   for  peptic  ulcer  disease.  Also  it  
is  the  first  manifestation  of  the  disease  in  about  2%  of   duodenal  
ulcer  patients.  Whether,  the  eradication  of  H.  pylori  will  reduce  this  
complication  has  lead  many  investigators  to  find  out  the  presence  
of  Helicobacter pylori  in  duodenal  ulcer  perforation. 
 12The  present  study  is  done  to  find  out  the  incidence  of   
Helicobacter pylori  in  duodenal  ulcer  perforation,  making  use  of  
RUT  and  Geimsa  staining  as  the  previous  studies  quoted  did  not  
have  the  advantage  of  a  definite  and  sensitive  staining  method  to  
detect  H. pylori. 
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AIM  OF  STUDY 
To  study  the  incidence  of  Helicobacter   pylori  in  a  case  of  
duodenal  ulcer  perforation  in  Government  Vellore  medical  college  
&  hospital 
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                     REVIEW  OF   LITERATURE 
 
DUODENAL  ULCER: 
The  duodenum  extends  from  the  pylorus  about  20 – 30  cms  
and  end  at  the  ligament of  Treitz. The duodenum  is  divided  into  
four  anatomic  parts. 
D1  - the cap / bulb 
D2  - descending  portion 
D3  - transverse  portion 
D4  - ascending  portion 
90%   of  ulcers usually  occurs   in  the  duodenal  cap  region 
The  central  issue  that  likes  all  theories  for  peptic  ulcer  
disease  is  acid.  Acid  must  be  present  for  non-malignant  ulceration   
of  the  upper  gut  to  occur.  The degree  of  acid  secretion  varies  with  
the  individual   disease  state  ranging  from  the  extreme  hyper  acidity  
of  Zollinger – Ellision  syndrome  to  the  hypoacidity   present  with  
type  I  and  IV  gastric  - ulcer.38 
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Epidemiological  studies  showed  a  strong  association  mainly  
between  Helicobacter pylori  infection  &  both  gastric  & duodenal  
ulcer  disease.  Treatment  of  the  infection   showed  greater  results  in  
long – term  cure  of  peptic  ulcers.  5The  cause  of  peptic  ulcer  is  
complex  multifactorial,  as  they  result  from  interplay  of  effects  of  
gastric  acid  and  pepsin  &  the  gastric  mucosal  barrier.  Any  entity  
that  either  increases  acid  &  pepsin  secretion  or  weakens  gastric  
mucosal  barrier  can  result  in  ulcers.   
Also  Gastric  stasis  causes  peptic  ulceration  by  inadequate  
clearance  of  normal  amounts  of  acid  &  NSAIDS  disrupt  the  
prostaglandin – driven  support  of  the  mucosal  barrier. 
Recently  works  have  shown  100%  association  of  Helicobacter  
pylori  in  patients  with  duodenal  ulcer.  Evidence  suggests  that  
eradication  of  the  H. pylori  bacteria  has  led  to  a  decreased  
recurrence  rate  and  greatly  supports  the  hypothesis  that  H-pylori  is  
an  etiologic  factor. 
Aetiology of  Duodenal ulcer: 
- Most  commonly  it  is  present   O +ve  in  blood  group   
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-  Among  all  the  most common  etiological  factor  is  Helicobacter 
pylori infection  &  it  carries  about  90% 
-   NSAIDs,   Steroids. 
-   Alcohol,   Smoking   and  also  vitamin  deficiencies  can  cause 
-  Zollinger – Ellison  syndrome,  MEN,  Hyperparathyroidism  are  all  
some  endocrine  causes 
-   Even   stress  &  anxiety  can  cause  duodenal  ulcer 
PATHOLOGY:   
Ulcers  often  occurs  in  duodenum  first  part,  mainly in  the first  
inch  of  it. Involves  mainly  the  muscular  layer  of  the  duodenum.  
Ulcer   causes  cicatrisation  leading  to  pyloric  stenosis.   
37Serosa  lying  over  the  duodenal  ulcer  often  shows  petechial  
haemorrhages  with  speckled  red  dots,  giving  appearance  of    
sprinkled  cayenne  pepper. 
When  microscopically  seen,  the  ulcers  are  found  with  chronic  
inflammation,  granulation  tissue,  gastric  metaplasia  of  duodenal  
mucosa, and  also  with  endarteritis  obliterans. 
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Kissing  ulcers  are  two  ulcers  lying  opposite  involving  anterior  
and  the  posterior  surface  of  duodenum.  Anterior  ulcers  often  goes  
for  perforation  &  the  posterior  ulcer  goes  for  bleeding. 
 
CLINICAL  MANIFESTATIONS: 
In  our  country,  ratio  of  the  ratio  of  duodenal  ulcer  to                          
gastric  ulcer  is  30 : 1. 
Commonly  it  involves  all  socio  economic  groups,   more  
commonly  involving  stressed  professionals.  (Type A personality) 
- usually  presents  with  “hunger  pain”  ( pain  more  before  food,  
in  early  morning  &  decreases  after  taking  food )  Night  pains  
are  also  more  common. 
- It  commonly involves  males 
- Periodicity  is  more  common  when  compared  to  gastric  ulcer 
- Vomiting,  heart  burn, and  also  water – brash  can  occur 
- Hematemesis  and  malena  can  occur 
- Increase  in  appetite  and  increase  in  weight  gain 
- Loss  of  weight  &  appetite  occurs  once  the  ulcer  going  for  
stenosis 
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- Patients  often  eats  more  frequently  with  out  any  restrictions 
- Chronic  duodenal  ulcer  can  be  in  either  uncomplicated  or  
complicated  forms 
 
 
COMPLICATIONS  OF  DUODENAL  ULCER: 
Perforation 
Bleeding 
Obstruction  (pyloric  stenosis:  mainly  due  to  scarring  and  
cicatrisation  of  duodenal  first  part  due  to  chronic  ulcer) 
PERFORATION: 
There  will  be  a  severe  dyspepsia  for  few  days  prior  to  the  
perforation  mainly  in  chronic  peptic  ulcer  cases.  Also  there  will be  
no  premonitory  symptoms  when  an  acute  ulcer  perforates  in  a  
younger  patients. 
A  sudden  excruciating  epigastric  pain  will be  present  at  the  
time  of  perforation.  Subsequent  symptoms  mainly  depends  on  the  
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degree  of  peritoneal  soiling  &  if  the  perforation  is  sealed  by  
greater  omentum. Also  the  pain  becomes  generalized  later.  Patient  
may  also  have  an  referred  shoulder  pain  mainly  due  to  
diaphragmatic  irritation.  The  contents  from  gastro  duodenum  may  
spill and  spread  along  the  right  paracolic  gutter  and  become  
localized  in  right  iliac  fossa  and  mimic  acute  appendicitis.  Vomiting  
is  usually  uncommon,  till  the  paralytic  ileus  is  established. 
41In  elderly  and  seriously  ill  patients,  perforation usually  
develops  very  gradually  with  generalized  peritonitis  with  fewer  
intense  symptoms  and  signs.  Depending  on  the  degree  and  the  rate  
of   peritoneal  soiling,  the  physical  signs  varies. 
Abdominal  tenderness  with  guarding  may  be  localized  to  
upper  quadrant  to  generalized.  If  the  contamination  spreads  and  
involves  whole  of  the  abdomen,  then  a  marked  board  like  rigidity,  
rebound  tenderness  and  a silent  abdomen  will be  present. After  the  
onset  of  paralytic  ileus,  abdominal  distension  occurs  because  of  the  
subsidence  of  the  musculature  in  the  anterior  abdominal  wall.  Also  
a  variable  degree  of  failure  in  the  peripheral circulation  will  occur,  
which  may  present  as  tachycardia,  hypotension,  cold  peripheries,  
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reduced  urine  output.  The  respiration  will be  very  shallow  and  
grunting. 
Diagnosis  is  done  mainly  based  on  the  symptoms,  signs  and  
the  plain  abdomen  &  chest  radiograph  taken  in  an  erect  posture.  
Lateral  decubitus  position  can  be  used  in  a  very  ill  patients.  Sub-
diaphragmatic  air  on  the  right  side   is  pathognomonic  of  gastro  
duodenal  perforation.  Paralytic  ileus  may  be  present  in  more  
advanced  cases.  36If  pneumoperitoneum  is  not  seen  radiologically,  
then  differentiation  between  sealed  perforation  and  acute  pancreatitis  
has  to  be  made.  If  doubt  persists,  then  a  diagnostic  peritoneal  
lavage or  tap  has  to  be  done. 
Management :  first  step  in  treatment  should  be  to  correct  
hypovolemia  and  electrolyte  imbalance.  Proper  peripheral  circulation  
and  proper  urine  output  should  be  present  for  an  operative  
management.  Colloids  are  used  for  resuscitation  measures. Oxygen  
support  given.  Pain  should  be  relieved  before  physical  examination. 
Intramuscular  pethidine  is  usually  very  effective.  Nasogastric  
aspiration  to  be  done.  Broad  spectrum  antibiotics  given.   
Some  patients  can  be  treated  conservatively  with  nasogastric  
tube  aspiration,  iv  fluids,  antibiotics,  analgesics,  PPI  or  H2 blockers  
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followed  by  upper  gastrointestinal scopy  after  the  acute  illness  get  
settled.  Main  problem  with  conservative  treatment  is patient  can  
develop  residual  abscess  in  subphrenic  region  which  requires  
drainage. 
 
 
37Open  surgical  technique  consisting  perforation  of  duodenum  
using  Graham’s Omental patch  is  the  most  commonly  performed  
technique.  Closure  followed  by  thorough  peritoneal  lavage  using  3  
litres of  warm  normal  saline should  be  given. Insertion  of  abdominal  
drains  done.   
HELICOBACTER  PYLORI  : 
In  1982,  Marshall  &  Warren  from  Australia  cultivated  a  
spiral  organism similar to Campylobacter  colonizing  the stomach  of   
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human  were  present  in  patients  with  type – B  gastritis (chronic  
inflammation  of  stomach  antrum)    It  was  then  named   as  
campylobacter  pyloridis which  was  then  changed  to  the  term 
campylobacter  pylori.  12But  the  organism  was  considered  varying 
taxonomically  from   other  campylobacter  species,  because  of  the  
presence  of  sheathed  flagella,  a  unique  fatty  acid  profile,  a different  
respiratory  quinines  and  a  different  16s  RNA  sequence,  and  as  a  
result  they  created  a  new  genus  Helicobacter.   During  the  past  five  
years  the  greater  expansion  occurred  and  now  it   includes  12  
species, among  those  most are  of  non  human  origin  and  are  not  
pathogenically  significant.It  is  more  common  in  the  lower  
socioeconomic  group. 
Helicobacter  pylori  is  associated mainly  with peptic  ulcer,  
gastritis(type – B),   gastric  associated  lymphoid  tissue (MALT) B- cell  
lymphomas,  gastric  adeno carcinoma. 
Duodenal  ulcer  -  95% 
Gastric  ulcer      -  70% 
Gastritis              -  70 – 90% 
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H. pylori   releases  enzymes  mainly  like  UREASE  that  
hydrolyzes  urea  & releases  ammonia  which  through  negative  
feedback  mechanism  increases  gastrin  release  from  G – cells.  
Also  secretes  dehydrogenase  (that  converts  alcohol  to  
aldehyde  which  is  very  toxic  to  the  mucosa),  endopeptidase (disrupts  
mucosal  barrier). 
12Urease  creates  an  alkaline  environment  around  it  in  mucus  
layer  of  gastric  epithelium.  It  can  survive  only  in  gastric  epithelium  
or  gastric  metaplasia  in  the  duodenum  or  barett’s  esophagus  or  in  
heterotropic  gastric  mucosa  in  meckel’s  diverticulum  or  rectum.  
Because,  receptors  for  these  organisms  to  adhere  into  mucosa  are  
available  only  in  gastric  mucosa. 
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Helicobacter  pylori   impairs  mucosal  healing  and  also  causes  
degranulation  of  eosinophils.  It  also  releases  many  number  of  
proteases  &   lipases  which  breaks  mucus  &  the  barrier. It  also  
secretes  cytotoxins such  as   (cag A  and  vac A).  These causes  
inflammatory  reaction  or  malignancy. 
 Normal  duodenum  harbor  the  bacteria   H. pylori,  duodenum  
having  gastric  metaplasia  can  be  infected  by   the  organism.  This  
tells,  why  the    Helicobacter pylori   are   involved  in  causing  the  
duodenal  ulcer.    
HABITAT : 
In  human  stomach,  it  is  mainly  present  in  the mucous  layer  
of  gastric  epithelium  mostly involving  the  antrum. Also  it  is   
documented  that  theseorganisms  can  also   be  cultured  from  
metaplastic  gastric  epithelium  in  the  duodenum. 
BLOOD :     Recently,  Helicobacter  pylori  were  also   recovered   
from  the  blood  culture  of  a  patient  having  malignant  lymphoma  of  
the  upper  GIT  including  stomach. 
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ORAL  CAVITY: 
H  pylori   occasionally  was   isolated  from  the  saliva  and  from  
dental  plaques.   Recovery  from  the   Oral  cavity  is   very  difficult. 
FAECES ;   Polymerase  chain  reaction  are  successfully  done   to  
identify  the  Helicobacter  pylori  in  faeces  at  a   greater  frequency. 
ANIMAL  SOURCES : 
H  pylori  are  isolated   from  various  animal  species. 
Including rhesus  monkey,   baboon,  pigs&  domestic  cats. 
Rhesus  monkey  is  the  only  natural  reservoir. 
ENVIRONMENTAL  SOURCES : 
No  free  Helicobacter  pylori  are  been  isolated  from   soil,  
water   or  other  environmental  sources. 
MICROBIOLOGICAL  FEATURES : 
Cellular  morphology :  2Helicobacter  pylori  is  a  gram  negative,   
curved  rod  or  S  shaped  (0.5  -  0.9  micro  meters  wide  and    2-4  
micro  meters  long).  It  has 1  to  3  turns  when  observed  in  vivo.      
In  blood  agar  cultures  (in  vitro)  no  spores  were  formed.   Using  
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light  microscopy,  Helicobacter  cells  found  to  have  about  5-6  polar  
(lophotricate)  flagella  filaments  at  2  days  of  growth.  They  are  
highly  motile  via  polar  flagella &  produce  an  abundance  of  urease. 
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Colonial  Morphology :Colonies  from  primary  culture  on  
supplementation  with  blood  agar  at  370C  takes  around 3 – 5  days  to  
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appear  &  are  circular  (1-2  mm).  they  appear  convex  and  
translucent. 
Coccoid  Bodies :  Older  cultureshows  a  morphological  change  
from  bacillary  to  coccoid  forms  along  with  a  loss  in  culturability. 
These forms  can  be  found  in  faeces  and  could  also  be  responsible  
in  oro-faecal  route   transmission  between  humans 
Physiological  Properties :Helicobacter pylori are microaerophilic  
and  grows  well  in  an  atmosphere  of  5%  O2  with  5  -  10%  CO2,  
on  blood  containing  media  like “  brain  heart  infusion  agar ”(BHI).  
BHI  contains  5%  horse  blood  agar  mainly  supplemented  with  1%  
Isovitalex.  All  strains  grow  over  a  relative  narrow  temperature  
range  of  33  to  40  degree  Celsius. Grow  over  a  wide  range  of   pH  
5.5 – 8.5. 
Biochemical  Properties : 
Positive  Features   Negative  Features 
Catalase  production  Carbohydate  Oxidation / fermentation              
Cytochrome  Oxidase  Hippurate  hydrolysis     
Urease  Production  Nitrate  reduction 
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Virulence  Factors : 
Promote  Colonization  Induce  Tissue  Injury 
Motility    Lipopolysaccharide  (LPS) 
Induction  of  hypochlorhydria Leukocyte  recruitment  and 
     Activating  factors 
Urease  Production  Cag  A  and  Vac  A  proteins 
Adherence    Heat  shock  protein 
Ptype  ATPase 
Urease :  The  enzyme  urease  has  nickel,  that  digests  urea,  
which  passes  freely  from  plasma  into  the  gastric  juice.  Finally,  
alkali  is  produced 
NH2-CO-NH2  +  H2O  →  CO2  +  2NH3  Then  spontaneously  
at  neutral  pH 
NH3  +  H2O   →  NH4OH  →  NH4+   +  OH- 
2In  Helicobacter  pylori  infected  patients,  the  gastric  juice  
contains   less  urea  and  more  ammonium  than  the  normal.  Ammonia  
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generated  by  H. pylori  Urease  activity  buffers  the  bacterial  hydrogen  
ions  in  gastric  acid  juice,  and  provides  a  source  of  nitrogen  for  H  
pylori.  Besides  its  protective  role,  ammonia  may  also  alter  the   
permeability  of  gastric  epithelium,  and  mucous  ionic  integrity  and  
also  it diffuses  hydrogen  ion  back  towards  the gastric  mucosa,  
resulting  in  mucosal  injury.  
MODE  OF  SPREAD : 
The  route  of  transmission  is  still  unknown.  The  high  rate  of  
infection  in  children  from  H  pylori  positive  parents  and  the  
presence  of  the  same  strain  within  members  of  the  same  family  
suggest  that  close  contact  is  very  important  for  the  spread  of  
infection.  Animal  studies  revealed  oral-oral  transmission.In  80 – 90 %  
of  population,  infection  is  feco-oral  route. 
Iatrogenic  person  to  person  transmission  via  endoscopes  has  
been  reported,  and  the  high  prevalence  of  infection  among  
endoscopists  those  who  do  not  use  gloves,  suggest  that  transmission  
occurs  through  instruments  contaminated  with  gastric  secretions. 
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PATHOGENESIS  &  IMMUNITY : 
Is  a  remarkable  bacterium  in  its  ability  to  establish  life - long  
colonization  in  the  stomach  of  untreated  humans.  Multiple  factors  
contribute  to  the  gastric  colonization,   inflammation,  alteration  of  
gastric  acid  production,  &  tissue  destructionthat  are  characteristic  of  
H. pylori  disease.  Initial  colonization  is  facilitated  by  a) bacterial  
acid  inhibitory  protein  which   blocks  acid  production  &  b)   bacterial  
urease  activity  produces  ammonia  that  neutralizes  gastric  acid. 
7The  actively  motile  H.  pylori    then  passes  via   the  gastric  
mucus  and  then  adheres  to  the  gastric  epithelial  cellsby  multiple  
surface  adhesion  proteins.  Surface  proteins  can  also  bind  host  
proteins  &  help  the  bacteria  evade  immune  detection.  Urease  
byproducts,  mucinase,  phospholipases  can  cause  localized  tissue  
damage  and  the  activity  of  the  vacuolating cytotoxin  A (Vac A),  a  
protein  that  after  endocytosis  by  epithelial  cells,    producing  
vacuoles  and  damages  the  cells.   
One  more  factor  is  cytotoxin – associated  gene (cag A)  that  
resides  on  a  pathogenicity  island  containing  approximately  30   
genes.  These  genes  encode  a  structure  that  acts  like  a  syringe  to  
inject  the  Cag A  protein  into  the  host  epithelial  cells,  which  
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interferes  with the  normal  cytoskeletal  structure  of  the  epithelial  
cells.  
The  cag  phosphoribosylanthranilateisomerase  (PAI) genes  also  
stimulates interleukin – 8 (IL-8)   production,  which  attracts  
neutrophils.  Neutrophils  releases  Reactive  Oxygen  Molecules  and  
proteases that causes  gastritis  and  gastric ulcers. 
H  PYLORI  AND  DUODENAL  ULCER : 
More  than  50 %  of  people  world  wide  harbor  H.pylori  
infection  but  less  than  10 %  of  those  infected  with  PUD.   
Number  of  factors  determine  whether  H.pylori  infection  causes  
disease: 
- Histologic  gastritis  induced  pattern 
- Alteration  in  homeostasis  of  gastrin  &  acid  secretion 
- Gastric  metaplasia  acquiring  in  the  duodenum 
- H.pylori  interaction   with  the  mucosal  barrier 
- Strain  of  H.pylori  present 
In  patients  with   duodenal  ulcer,   inflammation,  severity,  
infection,  density  are  greatest  mainly  in  the  distal  antral  region.  The  
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acid  secreting  body  mucosa is  spared. In  response  to  stimulation  
with  gastrin,  duodenal  ulcer  patients  with  H.pylori  produce  more  
acid  than  infected  patients  without  ulcers.  This  may  result  from  an  
impaired  acid  secreting  ability  of  the  nonulcer -  H.pylori  infected  
patient’s  more  diseased  acid  secreting  fundus  mucosa.  Increased  
gastric  acid  can  lead  to  the  development  of  gastric  metaplasia  in  
duodenal  bulb.  This  is  a  necessary  forerunner  to  colonization  of  the  
duodenal  epithelium  with  H. pylori.  7The  metaplastic  H.pylori  
colonized,  duodenal  epitheliumthen  becomes  more  susceptible  to  
acid  &  pepsin  effects  and  ulceration.  After  the  eradication  of  H. 
pylori  infection,  gastric  metaplasia  in  the  duodenum  does  not  revert  
to  normal,  but  with  elimination  of  infection,  the  risk  of  ulcer  
recurrence  is  eliminated. 
16H. pylori  infection  alters  the  gastrin  release  negative  
feedback somatostatin  secreted  by  antral  D cells.  Somatostatin  causes  
inhibition of  gastrin  by  paracrine  effect.   The  bacteria  produces  
alkaline  ammonia    on  both  the  surface  epithelium  &  in  the  antral  
glands prevents  the  D  cells  from  properly  interpreting  the  level  of  
acid  present.  This  leads  to  low  levels of  somatostatin,  thus  loss   of  
gastric  inhibition.  Chronic  hypergastrinemia  caused  by  H.  pylori 
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exerts  a  trophic  effect  &  hyperplasia  of  the acid  secreting  parietal  
cells. 
 
 
Infection  with H.  pylori  also  interferes   with  the  neural  
connections  b/n  antrum &  fundus  that  down  regulates  acid  
production.  This  impaired  neural  control,  coupled  with  
hypergastrinemia  leads  to  further  increases  in  acid  production.  With   
H. pylori  eradication, hypergastrinemia  rapidly  resolves.  There  is  a  
great  deal  of  variations  in  the  virulence  of  different  strains  H. 
pylori.  More  virulent  strains  have  increased  production  of  toxic  
enzymes  &  tend  to  be  more  adherent  to  the  mucosa.   They  appear  
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to  produce  more  urease  that  catalyzes  the  production  of  ammonia,  
further  enhancing  their  potential  for  harm. Some  genotypes  of  H.  
pylori  appear  to  be  particularly  toxic   &  are  more  common  in  
patients  with  peptic  ulcers.  These  are vac A -positive  &  cag A-  
positive.  There  is  also  a  genetic  predisposition  to  acquire  H. pylori  
infection. This  has  been  demonstrated  in  monozygotic  &  dizygotic  
twins  with  the  increased  risk  in  monozygotic  twins. 
22Wyatt   et  al (1987)  first  emphasized,  the  relation  between  H  
pylori  gastritis, gastric metaplasia  and  active  chronic duodenitis .  A  
sequence  of  events  was  made  that  showed metaplasia  (acid–induced),   
infection  that  spread  from  the  stomach  and  following  colonization  
of  the  gastric  epithelium,  the  development  of  an  active  chronic  
inflammatory  cell  response  in  the  duodenum. 
Thus  H  pylori  infection  and  gastric  metaplasia(acid  induced)  
are  essential  prerequisites  for  the  development  of   duodenal  
ulceration  and  active  chronic  duodenitis. 
The  appearance  of  patches  of  gastric  mucus  types  of    cells  
among  the  absorptive  cells  over  the  duodenal  villi  is  called  gastric 
metaplasia.  It  is  restricted  mainly  to  the  epithelial surfacealthough  
the  parietal  cells  acquisition  occurring   in  chronic  duodenitis  might  
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show   a  parallel  glandular  metaplasia  which  could  conceivably  
contribute  to  the  local  acid  production. 
DIAGNOSIS  OF  H  PYLORI : 
Detection  of  H  pylori  can  be  based  on  methods : 
1. Invasive :  based  on  biopsy  samples  and  needs  endoscopy. 
a) Rapid  urease  test  (CLO / Campylobacter  like  organism Test) 
b) Histology 
c) Culture 
d) Polymerase  chain  reaction  (PCR) 
 
2. Non  Invasive : 
(a) Serology 
(b) Urea  breath  test 
I (a) : Rapid  urease  test : 
It  is  a  rapid  diagnostic  test  used  for  Helicobacter  pylori.  
Mcnulty  et  al,  first  described  the  test.  It  is  based  on   enzyme   
urease of  Helicobacter  pylori.  An  endoscopic  biopsy  is  put  into  a  
solution  having  urea, (phenol  red)  a  pH  indicator  and  a  gel  
contained  bacteriostatic  agent. If   H. pylori  are  present,  the  bacterial  
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urease  hydrolyses the urea   releases  twomolecules  of  ammonia  and  
one  molecule  of  carbondioxide.  It  raises  pH  and  alkalinise   the  
medium  changes  yellow colour to  red.  The  colour  change  is  assessed  
after  30  minutes  and  then  after  2  hrs  and  categorized  as  strongly  
positive,  moderately  positive  and  negative. 
The  greatest  advantage  of  this  Rapid  Urease  test  is,  it  can be  
done   in  the  endoscopy  room  immediately  after  taking  biopsy. 
Sensitivity  is  90%  and  the  specificity  is  98 %. 
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1 (b) :  HISTOLOGY :  
The  Biopsies  taken  should  be  immediately  treated  in a  fixative  
solution -Bouin’s  solution.  10%  formaldehyde  can  also  be  used.  The  
use  of  fixative  is  to  prolong  the  delay  before  testing. 
By  using  a  standard  haematoxylin  and  eosin  stain,  
Helicobacter  pylori  can  be  identified  which   appears  rose  colored  
(taylor  and  others – 1987) 
Warthin – Starry Stain,  a  silver  stain helps  in  identifying    small  
amount   of  bacteriapresent,  but  it  doesn’t  work  in  case  of   
histological  tissue  samples.  Bacteria  stains  black  on  a  yellow  
background. 
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Genta  stain,  has  the advantage  of  both  stains  namely  HE,  a  
silver  stain,  and  the  other  one  is  Alcian  blue  at  pH  2.5. This  stain  
identifies  mucosal  morphology,  and  also  detects  low  density  
bacteriain  specimen  which  has  small  biopsy  with  abundant  debris  
just  like Warthin-Starry  Stain. 
This  is  cost  effective  &  feasible  just  like  all  other  silver  stain  
with  good  detection  rate. 
Sensitivity  is >  99%  vs  85%  with  H-E  stain. 
1 (c) :  CULTURE :  
H.  pylori  adheres  to  the  gastric  mucosa  and  is  not  recovered  
in  stool  or  blood  specimens.  Bacteria  can  be  isolated  in  culture  if  
the  specimen   is  inoculated  onto  enriched  medium  supplemented  
with  blood,  hemin  or  charcoal  &  incubated  in  a  microaerophilic  
atmosphere  for  upto  2  wks.  Viable  bacteria  are  detected  and  
antibiotic  sensitivity  can  be  obtained.  Takes  several  days  and  results  
are  dependent  on  the  expertise  of  the  operator  and  the  lab.  
Expensive  and  unnecessary  unless  antibiotic  sensitivity  are  required. 
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1 (d) :  POLYMERASE  CHAIN  REACTION : 
This  method  is  used  to  detect  Helicobacter  pylori  in  the  fecal  
samples.  PCR  is  more  sensitive  compared  to  all  culture  as  it  does  
not  depend  on  bacterial  viability.  But  the  limiting  factors  are  
inhibitors  of  amplification  reaction  in  feces. 
2 (a) :  SEROLOGY : 
Antibody  measurement  of  antibodies : 
Antibodies  against  Helicobacter   pylori  are  present  in  infected  
patients  and  the detection  of  such  antibodies  found  in  blood,  saliva,  
which  are  95%  sensitive  and  specific  for  H. pylori.  It  is  also  cost  
effective,  feasible,  and  time  limiting.  They  don’t  give  false  negative  
even  in  patients  on  Proton  Pump  Inhibitors,  Bismuth  and  
Antibiotics.  (NIH  Consensus  Conference,  1994). 
12Helicobacter  pylori  has  wide  variations  of  Antigenic  strains  
for  antibody  manufacture.  IgG  and  IgA  antibodies  found  in  blood  
are  Helicobacter  pylori  specific.  Compared  to  other  methods used   
for  testing  like  histology  and  cultures,  IgG  and  IgA  assays  have  
higher  sensitivity  and  specificity  and  so  these  methods  are  widely  
preferred. 
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 The  assays  in  practice  are  1)  Micro-titre  plate  assay 2)  Near  
patient  testing  devices.  These  assays  have  a  specific  cut  off   value  
and  a  control  sera  to  differentiate  between  infected  and  non  
infected.  These  two  assays  have  high  potential  compared  to  the  
standard  used  techniques. 
Helicobacter  pylori  antibodies  found  in  saliva  and  serum  are  
equally  effective.  IgG  immunoglobulin  presents  in the  saliva  is  
measured,  rather  than IgA  which  could  not  differentiate  the  infected  
from  non infected. 
12Antibody  tests   are  non  invasive  and  cost  effective.  Near  
patient  version  can  be  performed  in  few  minutes  with  the  blood  
obtained  from  finger  prick.  Some  researchers  commented  that  
serology  testings  are  the  gold  standard  techniques  for  detecting  
Helicobacter  pylori  infection (Blaser  1990). 
Patient  whose  gastric  biopsies  positive  for  Helicobacter  pyori,  
are  found  to be  serology  positive.  Culture  and  histologic  biopsy  
reveals  infection  in  a  particular  inflammatory  site  of  stomach,  but  
serological  assays  covers  the  entire  stomach. 
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TABLE : SENSITIVITY, SPECIFICITY AND COST  OF  
DIAGNOSTIC  TESTS  FOR  H.PYLORI : 
Methods Sensitivity 
(%)      
Specificity 
(%) 
cost invasive 
Culture 98 100 ++++ Yes 
Histology 98 99 ++++ yes 
CLO 90 100 +++ Yes 
Breath 100 100 ++ No 
Serology 98 88 + no 
Quantity of antibody tests : 
Recently  researchers  (Nomura  and  colleagues),  have  diagnosed  
that  raised  level  of  circulating  antibodies  are  present  in  Helicobacter  
pylori  infected  patients.  The  viability  of  a  screening  test  is  
increased  if  these  test  can  assess  the circulating  concentration  of  
antibodies  against  Helicobacter  pylori  which  could  differentiate  
between  peptic  ulcer  disease  and  the gastric  cancer,  thereby  
increasing  the  diagnostic  significance. 
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Antibody testing after H pylori eradication:  
After  the  eradication  of  Helicobacter  pylori,  the  serum  IgG  
and  IgA  levels  falls  very  slowly.  After  6  weeks  of  eradication,  
titres  falls  by  20-30%  and  after  six  months  titres  falls  by  50%  in  
97%  of  patients.12  Since  there  is  a  slow  fall  in  the  antibody  titre,  it  
is  not  commonly  used  to  assess  the  success  of  treatment.  Thus  the  
success  of  treatment  is  assessed  by  repeat  endoscopy,  histology  and  
culture  and  urea  breath  test.  One  study  showed  that  antibody  titre  
in saliva  specific  to  Helicobacter  pylori  were  found  to  be  reduced  
more  fastly.  More  than  50%  patient  have  shown  83%  fall  in  
antibody  titre  of  saliva  with  treatment  after  one  month. 
Thus  it  is  used  as  standard  methods  to monitoring  
Helicobacter  pylori eradication.  ELISA  is  the  best   method  for  
serology  because  of  its  simplicity,  reliability,  and  low  cost.  
Seroconversion takes  22-23  days  after  the  infection.  
Sensitivity  and  Specificity  of  ELISA  is  over  90%. 
Immunoblotting   is  a  qualitative  serological  test  used  to  detect  
antibodies.  This  technique  includes  denaturing  of  bacterial  antigen  
which  were  separated  by  electrophoresis  and  then  put  in  
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nitrocellulose  membrane  where  it  enables  a  contact  with  the  serum  
which  is  going  to  be  tested.  This test  concludes  an  immunological  
humoural  response  from  an  infected  person  rather  to assess  the  
variability  of  antigenic  strain.  
2(b) : UREA BREATH TEST: 
C13  is  the  most  commonly  used  isotope  which  occurs  by  
nature  and an  isotope  of  non  radioactive  origin.   Bacterial  urease  
activity  is  the  basis  for  breath  tests.  Urea  along  with   enriched  C 
13,  is  then hydrolysed  in  the  stomach  by  the  enzyme  urease  
secreted  from  H. pylori  to  produce  two  molecules  of  ammonia  and  
one  molecule  of carbondioxide. As  it  comes  to  intestine  the  gas  
succumbed  into  the  blood  and  is  excreted  via  lungs  as  exhaled  air. 
Breath  samples  are  collected  before  the  administration  of  C 13  CO2  
is  then  calculated  using  an  isotope  ratio  mass  spectrometer  [IRMS]. 
C 14  is  also  used  but  involves  exposure  to  a  small  amount  of  
radioactivity  and  must  be  used  with  caution  in  pregnant  patients  
and  children.  C -14  is  measured  using  a  beta  counter. 
The  subjects  are  advised  to  be  in  a  fasting  state  before  
conducting  the test.  After  a  test  meal,  the  subjects  are  instructed  to  
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rinse  their  mouth  and  be  seated  for  30  minutes  duration  of  the  test.  
The  breath  collection  is  usually  done  by  making  the patient  to blow  
into  a  tube  with  straw.  The  analysis is  performed  by  mass  
spectrometry / beta  counter. 
HELICOBACTER PYLORI  ERADICATION  REGIMEN: 
29Triple  therapy  includes  2  antibiotics and one proton pump 
inhibitor for 7-14 days. 2-week therapy with omeprazole, amoxicillin, and 
clarithromycin achieved a significantly higher eradication rate than 1- or 
2-week regimens with metronidazole. 
- PPI ( omeprazole 20 mg bid  or  rabeprazole 20mg  bid  or  
lansoprazole30 mg bid  or  pantoprazole  40mg bid) 
- amoxicillin 1 g  bid 
- clarithromycin  500mg bid 
- metronidazole 500mg bid (can be used  instead of amoxicillin) 
Four  quadrant  regimen  includes  triple  regimen  plus  bismuth  
subsalicylate.  
A longer duration of treatment (7 vs 14 days) may be more 
effective in curing infection but this remains controversial.  A meta-
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analysis suggested that extension of PPI-based triple therapy from 7 to 14 
days was associated with a 5 percent increase in eradication rates. Most 
studies included were based upon amoxicillin-based triple therapy. 
REVIEW OF LITERATURE:( Previous Studies) 
Edward C.H.Chung  Surgical  unit, United  Christian  Hospital, 
Kwnutong, Hong Kong. 
Using  an  urease  indicator  (CLO  test)  the  Helicobacter  pylori  
prevalence  among  peptic  ulcer  perforation  was  studied  prospectively.   
Of  59  subjects, 44 PDU    (84%  positive  for  CLO) 
15 PGU    (67%  positive  for  CLO) 
Subjects  who  have  perforation  were  initially  documented  to  
have  peptic  ulcers,  were  predominantly  CLO  test + ve,  then  
concluding  that  ulcer  relapse  is  because  of  Helicobacter  pylori  
which  also  got  supporting  evidence  by  a  latest  H. pylori  eradication  
studies  done  on  non-perforated  ulcers. 
All  adult  patients  diagnosed  as,  and  operated  for ,  perforated  
peptic  (gastric  and  duodenal)  ulcer  within  the  12  month  period  of  
march  1991  to  February  1992  were  prospectively  entered  into  this  
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study.  Cases  were  excluded  subsequently  if  the  perforation  was  due  
to   Causes  other  than  peptic  ulceration, e.g.,  tumours,  foreign  bodies. 
Details  of  previous  ulcer  disease  were  specifically  sought  and  the  
use  of  antibiotics,  non-steroidal anti-inflammatory  drugs  (NSAIDs),  
Steroids,  medications  for  peptic  ulcer  by  subjects  within  the  
preceding  one  week  were  also  ascertained. 
Discussion 
H. Pylori  infection  is  frequently  seen  among  peptic  ulcer  
patients  in  Hongkong.  The  prevalence  rates  reported  in  two  recent  
local  studies  are  67%  for  gastric  ulcer   and  84%  for  duodenal  
ulcer. ”the  corresponding  figures  for  PGU  and  PDU  of  53.3%  and  
86.4%  derived  from  this  survey  are  comparable. Detection  of  
H.pylori  within  the  ulcer  especially  duodenal  ulcer  is  generally  
difficult  because  an  ulcer  crater  represents  an  inhospitable  place  for  
this  fastidious  microbe. 
Conclusion: 
This  study  has  demonstrated  that  H. Pylori  is  present  both  at  the  
ulcer  edge  and  antrum  in  a  large  percentage  of  perforated  ulcers  
and  ulcer  relapse  in  the  form  of  perforation  is  probably  correlated  
with  pre-existing  H. pylori  infection. What  remains  to  be  evaluated  
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is  the  relationship  between  the  presence/absence  of  infection  and  
future  relapse,  and  perhaps  also  H. pylori  eradication  and  relapse,  in  
PPU  patients  treated  with  simple  repair  only. 
                        
 ANTRUM ULCER EDGE NO: OF 
SUBJECTS 
PDU 
+ + 18 
+ + 15 
- + 5 
- - 6 (Total -44) 
PGU 
+ + 4 
+ - 3 
- + 1 
- - 7 Total – 15) 
Percentage  with atleast  one  site  positive:  PDU-86.4%  &  PGU 
– 53.3%             
Professor Vikram Kate,  professor of Surgery,  Jipmer, Pondicherry. 
Reports  on  association  between  H. pylori  infection  and   
perforated  duodenal  ulcer  are  conflicting  and  few. 
Following  a  simple  closure  after  perforation,  there  was  a  high  
prevalence  of  H.  pylori  infection  leading  to  relapse  of  duodenal  
ulcer (Sebastian et al) A report  from  Hongkong showed  80%  
association  of  H. pylori  infection  in  duodenal  ulcer  perforation.A  
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recent  North  India  report  also  showed  a    similar  association.  17  
patients  who  were  diagnosed  to  have  perforated  duodenal  ulcer  
were  found  to be  positive  for  Helicobacter  pylori  infection  and  these  
patients  were  followed up  for  a  period  of 10.9  weeks .  13  among  
them  had  active  duodenal  ulcer  while  among  the non  infected 
patients  ulcer  prevalence  was  found  to  be  nil.  Kate  et  al,  reported  
that  Helicobacter  pylori  associated  with  duodenal  ulcer  perforation  
does  not  vary  much  that  of  control,  but  at  every  follow  up  he  
found  that  infection  rate  was  assessed  to  be  high  among  patients  
who  had  persistent  or  residual  ulcer  following  a  simple  closure  
done  for  a perforation  duodenal  ulcer.   
31Reinbach et  al.  reported  that  the  prevalence  of  H. Pylori  
infection  in  patients  with  perforated  duodenal  ulcer  was  47%,  which  
was  similar  to  the  51%  seen  in  controls.  Other  reports  also  did  not  
find  an  association  between  perforated  duodenal  ulcer  and  H. pylori  
infection.  In view  of  these  conflicting  reports  there  is  a  need  for  a  
prospective  study  after  simple  closure  of  a  perforated  duodenal  
ulcer  to  determine  whether  eradication  of  H. pylori  reduces  the  
incidence  of  recurrent/residual  ulcer  after  simple  closure.  As  the  
association  of  H. pylori  occurrence  and  ulcer  recurrence  has  already  
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been  shown  by  our  earlier  study,  randomization  to  eradication  
therapy  and  no  treatment  arms  was  not  considered  necessary. 
Our  previous  study  using  the  standard  triple  drug  regimen  
with  metronidazole  as  one  of  the  drugs  failed  to  clarify  the  role  of  
eradication  rate  with  the  regimen  was  only  52%  at  12  months  
follow  up. Hence, a four-drug  regime  with  a  high  reported  
eradication  rate  was  chosen  now for  this  study. 
As  the  association  between  H. pylori  and  ulcer recurrence  was  
demonstrated  in  our  previous  study,  attention  was  focused  mainly  
on  the    effect  of  eradication  on  H. pylori  on  the  
persistence/recurrence  after  simple  closure.  The  results  of  the  
present  study  showed  that  in  the  eradicated  group,  the  ulcer  
persistence  or  relapse  rate  was  significantly  lower  at  18.6%  
compared  to  the  70%  seen  in  the  non- eradicated  group. 
In  conclusion, we  can  state  that  H. pylori  infection  does  play  
an  important  role  in  duodenal  ulcer  relapse  following  simple  closure  
of  perforated  duodenal  ulcer.  Eradication   of  H. pylori  infection  
significantly  reduces  the  relapse  of  duodenal  ulcer.  Combining  acid  
reducing  surgery  with  Omental  patch  closure  is,  therefore,  not  
necessary  for  ensuring  cure.  Hence,  anti H.pylori  therapy  using  
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regimens  with  high  eradication  rates  should  be  prescribed  for  all  
patients  with  perforated  duodenal  ulcer  who  are  positive  for  
H.pylori  infection  after  simple  closure. 
Racial differences  in  Helicobacter  pylori  seroprevalence  in  
Singapore: 
 
33Correlation with difference  in  peptic  ulcer  frequency.  
Helicobacter  Pylori  Journal  of  gastroenterology  & hepatology.  12 
(9/10) : 655-659  October  1997. 
The  aim  of  this  study  was  to  determine,  whether  racial  
differences  exist  in  the  seroprevalence  of  Helicobacter  pylori 
infection  in  Singapore,  and    whether  these  difference  correlate  with  
racial  differences  in  peptic  ulcer  frequency.  A commercial  
serological  test  for  immunoglobulin  (IgG)  antibody  to  H. pylori  
which  was  90%  sensitive  and  83%  specific  in  our  population  was  
used  to  screen  403  adult  blood  donors  of  Chinese,  malays  and  
Indian  origin,  aged between  15 – 60 years.  Serum  specimens  from  84  
paediatric  patients  admitted  to  the  paediatrics  Department,  national  
university  of  Singapore,  with  non-gastroenterological  illnesses  were  
also  tested.  In  all  three  races,  seroprevalence  of  H. pylori  increased  
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with  age.  Indians  have  the  highest  prevalence  of  infection  followed  
by  Chinese  and  Malays.  Peptic  ulcer  prevalences  are  known  to  be  
highest  in  Chinese,  followed  by  Indians  and  Malays.  33The  Malays  
have  the  lower  prevalence  of  H.pylori  and  peptic  ulcer  among  the  
three  races  in  Singapore.  Indians  have  a  higher  prevalence  of  H. 
pylori  antibodies  but  a  lower  frequency   of  peptic  ulcer  than  the  
Chinese.  Racial  differences  in peptic  ulcer  frequency  between  
Chinese  and  Indians  are  not  explained  by  the  prevalence  of  H. 
PYLORI 
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MATERIALS AND METHODS 
Thirty   patients  who  underwent  surgery  for  perforated  
duodenal  ulcer  on  emergency  basis  in  the  department  of  general  
surgery  in  Government vellore medical  college  between  August 2014  
to  July  2015  were  included  in  this  study. 
Inclusion  criteria 
1) Patients  between  18-70  years  of  age. 
2) Patients  having  perforated  duodenal  ulcers. 
 
Exclusion  criteria 
1) Patients  below  18  years  and  above  70  years  of  age. 
2) Patients  on  NSAID’s  for  more  than  one  month  duration. 
3) Patients  who  have  received  Anti-Helicobacter  pylori  
treatment. 
4) Patients   with  gastric  ulcers  or  ulcero proliferative  growth. 
 
The   study   population   consisted   of   30  patients  between  age  
group  of  18 – 55  yrs.  Exploratory   laparotomy  was  performed  in  all  
cases.  Two  mucosal   biopsies  were  taken  through   the  perforation  
site.  40One  specimen  is  immediately  put  into  a  preformed  H.pylori  
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detection  kit  for  rapid  urease  test  (RUT),  which  shows  the  presence  
of  urease  producing  bacteria  by  a  change  in  the  colour  of  the  
medium  within  a  time  frame  which  is  read  as  follows: 
1. If  a  pink  color  develops  within  30mins  the  test  is  taken  as  
strongly  positive. 
2. If  a  pink  color  is  not  developed  within  half  an  hour  but  
develops  within  two  hours  then  the  test  is  moderately  positive. 
3.  If  a  pink  color  is  not  developed  within  two  hours  but  develops  
within  24  hours  then  the  test  is  is  weakly  positive. 
4.  If  a  pink  color  is  not  develop  at  the  end  of  24  hours  then  the  
test  is  negative  for  H pylori. 
The  Second  biopsy  specimen  is  fixed  in  10%  formalin  solution  
and  subjected  to  genta  staining  in  the  department  of  department  of  
pathology.  This  is  a  novel  staining  procedure  that  allows  the  
unencumbered  observation  of  the  histopathologic  characteristics  of  
the  tissue  while  optimally  demonstrating  H. pylori. 
Formalin  fixed  duodenal  specimen  is  processed,  cut  into  4  
micrometer  sections  and  placed  on  regular  microscopic  slides.  To  
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melt  the  paraffin,  slides  are  dried  in  an  oven  at  60  degree  
centigrade  for  15mins  followed  by   microwaving  for  3mins.  Slides  
are  then  stained  according  to  the  following  procedure: 
1. Deparaffinize  the  sections   and  rehydrate  the  sections  in  
distilled  water. 
2. Sensitization  of   sections  is  done  by  placing  them  in  1%  
aqueous  uranyl  nitrate  at  room  temperature  for  three  minutes,  
followed  by  transferring    them  to  distilled  water. 
3. Rinse  Slides  in  distilled  water  thoroughly  as  there  is  chance  
for      cross  contamination. 
4. Keep  the  section  in  1%  AgNO3  (silver  nitrate)at  room  
temperature  and  then  heat  them  together. 
5. The  microwave  oven  should  be  setup  to  heat  below  boiling  
point. 
6. Rinse  slides  for  three times  in    distilled  water  until  the  chance  
of  contamination is  eliminated. 
7. Rinse   it  two  times  in   95%  alcohol. 
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8. Rinse   it  two  times  in  100%  alcohol. 
9. Keep   the  slides  in  2.5%  gum  acacia  for  5 mins. 
10. Air   drying  of  sections  is  done  for  1min. 
11. Rinse   it  two  times   in  distilled  water. 
12. Reduce   it  in  the  reducing  solution,  in  a  45  degree  centigrade  
water  bath  for  10 – 15 min or  until  the  sections  have  developed  
a  dark  brown  H. pylori  and  a  light  yellow. 
13. Rinse  the sections  in  water  to  stop  reduction . 
14. Stain  in  alcian  blue  with  pH  2.5  for  10  mins. 
15. Rinse   the  slide  in  running  tap  water. 
16. Stain   the  sections  in  hematoxylin  for  5 mins. 
17. Rinse   it  in  running  tap  water. 
18. Quickly   Dip the  slide   in  acid  alcohol. 
19. Rinse   it  in  ammonia  water  0.25%  until  it  turns  blue. 
20. Stain   the  sections  in  eosin  for  5 Mins. 
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21. Quickly   rinse  in  tap  water. 
22. Rinse   the  slide  twice  in  95% alcohol. 
23. Rinse   it  three  times  in  absolute  alcohol. 
24. Rinse  it  three times  in  xylene  and  place  the  coverslip  and  
examine  under  microscope. 
Reducing  solution:  10 ml  of  2.5 %  gum  acacia, 25 ml  of  2%  
hydroquinone, 5ml of  absolute  alcohol  and  2.5ml  of  0.04%  silver  
nitrate,  unfiltered. 
STATISTICAL  ANALYSIS : 
Descriptive  results  were  expressed  as  mean,  SD  and  
percentages,  qualitative variables  were  assessed  using  chi  square  test.  
Probability  value  (p value) was used  to   determine  the  level  of  
significance  p  value  <  0.05  was  considered  as  significant,  p value  < 
0.01  was  considered  as highly  significant. 
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PATIENT DATA 
CASE  STUDY  NO  : 1 
A  25  yrs  old  Dhineshkumar, engineering student   from vellore  
IP  No  :  3214,  presented  to  me  with  pain  abdomen   of   2  days   
duration,  h/o  vomiting&   fever  and    passing  scanty  urine  2  days  
and   constipation  of  2 – days Pt  is  a  Known  alcoholic,  smoker,  and a  
known    case  of  acid  peptic  disorder -  proved  to  have  duodenal  
ulcer   not  on  proton  pump  inhibitors,  not a known   asthmatic,DM, 
HTN. 
Palpation  findings  per  abdomen:  rigidity +,  diffuse  
tenderness  all  over  the  abdomen,  more  in  the  right hypochondrium  
and  epigastrium, guarding +, rebound tenderness +, 
Investigations:  complete blood count,  Rbs, Rft, blood urea, sr. 
creatinine, Serum electrolytes,  HIV,  HbsAg,  Xray  erect   abdomen,  
CXR-  PA  view,  USG  abdomen,  ECG,  Blood  grouping,  rh  typing   
Hb – 13gms, 
Blood   grouping – B   positive, 
RBS : 112 mgs 
B/U  :26 mgs  
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S/C  :0.8 mgs % 
Na+ : 140mEq 
K+  : 4.5 mEq 
Cl  : 102mEq 
HIV : Negative 
HBs Ag :Non  reactive 
X-ray  erect  abdomen -  Showed  air  under    the  diaphragm,  
suggestive  of  pneumoperitoneum 
USG  abdomen: moderate  free  fluid  in abdomen  and  pelvis- 
Patient  data :  PR : 102/min,  BP :  118 / 68 mm  Hg 
Cvs    :           S1 + S2  Normal,  RS : B/L  air  entry +,  
UOP  :            1200 ml 
Patient  was  diagnosed  with  pneumoperitoneum  -? hollow   
viscus   perforation,  resuscitated,  prognosis  explained,  High  Risk  
consent  taken,  and  planned  for  Emergency  Laparotomy 
Under  Epidural anaesthesia,   patient   put  in  supine  position ,  
parts painted  & drapped,  Upper  midline  incision  taken,  abdomen  
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opened   in  layers , peritoneum  opened,  bile  stained  peritoneal  fluid 
about 2 litres  sucked  out ,  about  1cm  x  1 cm  perforation  noted  in  1st  
part  of  duodenum  -2  bits  of   duodenal  mucosal  biopsy   taken  from  
perforation  site,  perforation  closed   with  no  2 - 0   vicryl  with  onlay 
omental  patch,  peritoneal  toilet  given  using  warm   saline  and  
bilateral  drains  fashioned  across  both  the  flanks -  left  in  the  pelvis  
and  right  in  the  right  sub  hepatic  area,  after  counting  instruments  
&  pads  and  checking  for  haemostasis , abdomen  closed  enmass  
using No : 1  prolene,  skin  sutured  with  No :1  mersilk,  aseptic  
dressing  applied. 
Patient  withstood   the  procedure  well, 
Immediate  post  operative  period  uneventful, 
The  biopsy  specimens  taken  were  subjected  one  for  RUT  test  
another  for  histopathology  to  pathology  laboratory. 
Patient  treated  with  NPO /  RTA,  IV  FLUIDS – 2500 ML / inj. 
piperecillin  +tazobactum 4.5 gmsBD /  Metrogyl500mg  TDS / amikacin  
500mg BD / pantaprazole  40mg / tramadol  100 mg / TPR / BP- 2ndhrly / 
I / O chart.  Patient  extubated after  2  days .Orals  were  started  on  day-
5.   Patient  drains  were  removed  on  day -7,  suture  removal  done  on  
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day - 9,  patient  was  advised  H.Pylori  kit,  and  advised  for  follow  up 
with upper GI endoscopy. 
                Chest  xray  showing  Air  under  diaphragm: 
 
 
Duodenal  ulcer  perforation 
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CASE  STUDY  NO  :  2 
A  40yrs  old Sekar , from   Ambur ,  IP  No  :  3044 ,  presented   
with  pain  abdomen  of    2  – days  duration,    distention  of  abdomen,  
vomiting 4-5  episodes / day,  fever -  2 days  and  constipation  of  2 – 
days 
Pt  is  a  Known  alcoholic,  smoker,  not  a  known  DM,  HTN,  
TB, Asthmatic 
Pt k/c/o   APD  takes  PPI  occasionally. 
Palpation  findings  per  abdomen:  distention  &  diffuse  
tenderness  all  over  the  abdomen,  epigastrium,Right  hypochondrium  
guarding +,  rigidity +, 
P/R  -  no  fecal  staining,   
Investigations:  complete  blood  count,  Rbs,Rft,  S/C,  B/u,  
Serum electrolytes,  HIV,  HbsAg,Xray  erect   abdomen,  CXR-  PA  
view,  USG  abdomen,  ECG,  Blood  grouping,  rh  typing 
Hp – 12.6gms, 
Blood   grouping – A -   positive, 
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RBS : 120 mg/dl 
B/U  :30 mg/dl 
S/C  :1.0mg/dl 
Na+ : 138mEq/l 
K+  :3.8 mEq/l 
Cl  : 112mEq/l 
HIV :Negative 
HBs Ag :Non  reactive 
X-ray  erect  abdomen -  Showed  air  under   the  diaphragm,  
S/O  hollow  viscus   perforation 
USG  abdomen:  minimal  interbowelfree  fluid  ,  absence  of  
peristaltic  movements  in  the  bowel  -  suggestive  of  hollow  viscus   
perforation 
Patient  data :  PR : 94/min,  BP :  108/74  mm  of  Hg 
Cvs :  Normal,  RS : Bilateral  air  entry + 
UOP :750 ml,  on  catheterization. 
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Patient  was  diagnosed  with ? hollow   viscus   perforation,  
patient  resuscitated,  prognosis  explained,  High  Risk  consent  taken,  
and  planned  for  Emergency  Laparotomy 
Under GA,  Patientput in  supine position,  parts  painted  
&drapped,  premedicated  , antibiotics  given, 
 Midline  incision  made ,  abdomen  opened   in  layers,  
peritoneum  opened,    bile  stained  peritoneal  fluid  about  1.5  litres 
sucked  out,   0.5 cm  x  0.5 cm  perforation  noted  in  1st  part  of  
duodenum  -2  bits  of   duodenal  mucosal  biopsy   taken  from  
perforation  site,  perforation  closed   with  no  2 - 0   vicryl  with  
onlayomental  patch,  peritoneal  toilet  given  and  bilateral  drains  
fashioned  across  both  the  flanks -  left  in  the  pelvis  and  right  in  the  
right  sub  hepatic  area,  after  counting  instruments  & pads  and  
checking  for  haemostasis  abdomen  closed   using No : 1  prolene,  skin  
sutured  with  No :1  mersilk,  aseptic  dressing  applied. 
Patient  withstood   the  procedure  well, 
Immediate  post  operative  period  uneventful, 
The  biopsy  specimens  taken  were  subjected  one  for  RUT  test  
another  for  histopathology  to  pathology  laboratory. 
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Patient  treated  with  NPO /  RTA,  IV  FLUIDS – 2500 ML / inj. 
Ceftriaxone   +sublbactum  1.5 gms  /  metrogyl500mg  BD / amikacin  
500mg / pantaprazole  40mg / tramadol  100 mg / TPR / BB- 2ndhrly / I / 
O chart. 
Orals  were  started  on  day- 5,   Patient  drains  were  removed  on  
day -6,  suture  removal  done  on  day  - 10,  patient  was  advised  
H.Pylori  kit,  and  advised  for  follow  up. 
 
 
Xray  abdomen  erect  showing  air  under  diaphragm: 
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DUODENAL ULCER PERFORATION 
 
CASE  STUDY  NO  :  3 
A  42yrs  old  male  patient,  Chidambaram ,  agricultural  labourer,   
from  gudiyatham,     IP  No  :  3954,  presented   with  pain  abdomen  
for 3 days  with  distention  of  abdomen,  vomiting8  episodes / day,  
fever  and  constipation  of  2 – days 
Patient  is  a  Known  alcoholic,  smoker,  known  patient  of  acid   
peptic  disorder,  treated  with  Antacids  not  a  known  DM, HTN. 
Palpation  findings  per  abdomen:  distention  &  diffuse  
tenderness  all  over  the  abdomen,  diffuse  guarding +,  board like  
rigidity +,  . 
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Investigations:  Complete  blood  count,  Rbs, Rft,   S/C,  B/U,  
Serum electrolytes,  HIV,  HbsAg, Xray  erect   abdomen,  CXR- PA  
view,   ECG,  Blood  grouping,  rh  typing   
Hp – 11.5gms, 
Blood   grouping – A+  positive, 
RBS : 96 mg/dl 
B/U  : 40 mg/dl 
S/C  : 1.1 mg/dl 
Na+ : 138mEq/l 
K+  : 3.9 mEq/l 
Cl  : 112 mEq/l 
HIV : Negative 
HBs Ag :Non  reactive 
X-ray  erect  abdomen -  Showed  air  under   the  diaphragm,  
S/O  hollow  viscus   perforation 
Patient  data : PR : 112 /min,  BP :  104 /64  mm  of  Hg 
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CVS : Normal,   
RS                    :   Bilateral  air  entry + 
UOP : 450 ml 
Patient  was  diagnosed  with  ? hollow   viscus   perforation,  
resuscitated,  prognosis  explained,  High  Risk  consent  taken,  and  
planned  for  Emergency  Laparotomy 
Under  Spinal  Anaesthesia,   Patient  put  in   supine position,  
parts  painted  & drapped premedicated,  antibiotics  given,  Midline  
incision  made,  abdomen  opened   in  layers  bile  stained  peritoneal  
fluid  sucked  out.  About   1  cm  x  0.5 cm  perforation  noted  in  1st  
part  of  duodenum  -2  bits  of   duodenal  mucosal  biopsy   taken  from  
perforation  site,  perforation  closed   with  no  2 - 0   vicryl with  onlay 
omental  patch,  peritoneal  toilet  given  and  bilateral  drains  fashioned  
across  both  the  flanks -  left  in  the  pelvis  and  right  in  the  right  sub  
hepatic  area,  after  counting  instruments  &  pads  and  checking  for  
haemostasis,  abdomen  closed   using No : 1  prolene,  skin  sutured  with  
No :1  mersilk,  aseptic  dressing  applied. 
Patient  withstood   the  procedure  well, 
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Immediate  post  operative  period  uneventful, 
The  biopsy  specimens  taken  were  subjected  one  for  RUT  test  
another  for  histopathology  to  pathology  laboratory. 
Patient  treated  with  NPO /  RTA,  IV  FLUIDS – 2500 ML / inj. 
Ceftriaxone   + sulbactum  1.5 gms  /  metrogyl500mg  TDS / amikacin  
500mg / pantaprazole  40mg / tramadol  100 mg / TPR / BB- 2ndhrly / I / 
O chart. 
Orals  started  on  day-  5,  Patient  drains  were  removed  on  day -
6,  suture  removal  done  on  day  - 10 ,  patient  was  advised  H.Pylori  
kit,  and  advised  for  follow  up. 
DUODENAL ULCER PERFORATION 
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XRAY  SHOWING  AIR  UNDER  DIAPHRAGM 
 
CASE  STUDY  NO :  4 
A  44  yrs  old  Srinivasan   IP: 6827 ,  agricultural  labourer  from  
ambur  Presented  with c/o fever,  vomiting,  pain   abdomen  and  
increasing   distention  of  abdomen  and  constipation  of  3 – days 
Patient  is  a  known  smoker,  alcoholic,  taking  steroids ,  not  a  
known  DM,  HTN, TB, Asthma 
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Palpation  findings  per  abdomen:  distention  &  diffuse  
tenderness  all  over  the  abdomen,  guarding +,  rigidity +. 
Investigations:  Complete  blood  profile,  Rbs,Rft,  S/C,  B/U,  
Serum electrolytes,  HIV,  HbsAg,  Xray  erect   abdomen,  CXR- 
PA  view,  USG  abdomen,  ECG,  Blood  grouping,  rh  typing   
Hb  :  14gms, 
Blood   grouping : A-  negative, 
RBS  :     110 mg/dl 
B/U   : 80 mg/dl 
S/C   : 2.2 mg/dl 
Na+  : 135 mEq/l 
K+   : 2.9mEq/l 
Cl   : 96 mEq/l 
HIV : Negative 
HBs Ag : Non  reactive 
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X-ray  erect  abdomen -  Showed  air  under  the  diaphragm,  S/O  
hollow  viscus   perforation 
USG  abdomen:  free  fluid  in abdomen  and  pelvis,  -  suggestive  
of  hollow  viscus   perforation 
Patient  data :  PR : 114 / min,  BP : 94 / ?mm  of  Hg 
CVS :  Normal,  RS : Bilateral  air  entry + 
UOP  :  nil 
Patient  was  diagnosed  with  ?  hollow   viscus   perforation,  
resuscitated,  prognosis  explained,  High  Risk  consent  taken,  and  
planned  for  Emergency  Laparotomy 
Under  GA, Patient  put  in   supine,   premedicated , parts painted  
& drapped  Midline  incision  made,  abdomen  opened   in  layers,   bile  
stained  peritoneal  fluid  about  2 litres  sucked  out.   About  1cm  x  1 
cm  perforation  noted  in  1st  part  of  duodenum  -2  bits  of   duodenal  
mucosal  biopsy   taken  from  perforation  site,  perforation  closed   with  
no  2 - 0  vicryl  with  onlay  Omental  patch,  peritoneal  toilet  given  
and  bilateral  drains  fashioned  across  both  the  flanks -  left  in  the  
pelvis  and  right  in  the  right  sub  hepatic  area,  after  counting  pads  
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&  instruments  and  checking  for  haemostasis  abdomen  closed  enmass  
using No : 1  prolene,  skin  sutured  with  No :1  mersilk,  aseptic  
dressing  applied. 
The  biopsy  specimens  taken  were  subjected  one  for  RUT  test  
another  for  histopathology  to  pathology  laboratory. 
Patient  treated  with  NPO /  RTA,  IV  FLUIDS – 2500 ML / inj. 
Ceftriaxone   + sulbactum  1.5 gms  /  metrogyl 500mg  tds / amikacin  
500mg / pantaprazole  40mg / tramadol  100 mg / TPR / BP- 2ndhrly / I / 
O chart. 
Orals  started  on  day – 4 . Patient  drains  were  removed  on  day 
-6,  suture  removal  done  on  day  - 9,  patient  was  advised  H.Pylori  
kit,  and  advised  for  follow  up. 
DUODENAL  ULCER  PERFORATION 
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XRAY  ABDOMEN  ERECT  SHOWING  AIR  UNDER  DIAPHRAGM 
 
 
CASE  STUDY  NO :  5 
A  62yrs  old  Elumazhai,  IP: 8782,  farmer  from  katpadi,  
Presented  with c/o  pain   abdomen  of  4- days  duration,  Vomiting>  15 
episodes,  fever > 3 days,   constipation  of  4 – days 
Patient  is  a  known alcoholic  for  20  yrs,  not  a  smoker. known 
DM under  treatment.Not  a  known  HT / Asthmatic / TB 
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Palpation  findings  per  abdomen:    diffuse  tenderness  all  over  
the  abdomen, more in the rthypochondrium, epigastrium guarding  
+,  board  like  rigidity +,  obliteration  of  liver  dullness +, 
Investigations:  Complete  blood  picture,  Rft,  Rbs,  S/C,  B/U,  
Serum electrolytes,  HIV,  HbsAg,  Xray  erect   abdomen,  Cxr-  PA  
view,  USG  abdomen,  ECG,  Blood  grouping,  rh  typing,  Serum  
Amylase,  Widal  test. 
Hb  : 9.8gms, 
Blood   grouping  : O+  positive, 
RBS  : 85 mgs 
B/U   : 52 mgs  
S/C   : 1.5 mgs 
Na+  : 136mEq/L 
K+   : 3.0 mEq/L 
Cl   : 110 mEq/L 
HIV  : Negative 
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HBs Ag  : Non -  reactive 
Widal Test  : Negative, 
X – ray  abd – showed  air  under   right  dome  of  diaphragm 
USG  Abdomen:  Bilateral  minimal  pleural  Effusion,  decreased / 
absent  peristaltic  movements  of  bowel  loops,   loculated   free  fluid  
in  the  abdomen. 
Patient  data  
 PR  : 98 / min 
BP   : 90 / 70  mm  of  Hg 
CVS : S1 + S2 – Normal, 
RS   : Bilateral  air  entry  +,  bilateral  ronchi 
UOP   : 850  ml 
Patient  was  diagnosed  with   hollow   viscus   perforation  
features  of  peritonitis,  resuscitated,  prognosis  explained,  High  Risk  
consent  taken,  and  planned  for  Emergency  Laparotomy 
Under  GA,  patient  put  in  supine  position,  parts  painted  & 
drapped Midline  incision  made,  abdomen  opened  in  layers,  
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peritoneum opened. Bile  stained  toxic  fluid  about  2  litres  drained.  
About  1 * 0.5  cm  perforation  noted  in  the  first  part  of  the  
duodenum.  Two  biopsy  specimen taken.  The  biopsy  specimens  taken  
were  subjected  one  for  RUT  test  another  for  histopathology  to  
pathology  laboratory. 
Patient  treated  with  NPO /  RTA,  IV  FLUIDS – 2500 ML / inj. 
Ceftriaxone   + sublbactum  1.5 gms  /  metrogyl  500 mg iv  tds / 
amikacin  500mg / pantaprazole  40mg / tramadol  100 mg / TPR / BB- 
2ndhrly / I / O chart / duolin nebulisation. 
Day #5  pt  shifted  from  ICU  to  Male  Post  operative  ward &  
orals  were  started.   Patient  Drains  were  removed  on  day  - 8,  suture  
removal  done  on  day  -10th ,  patient  was  advised  H.Pylori  kit,  and  
advised  for  follow  up. 
DUODENAL  ulcer  perforation 
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Xray  abdomen  showing  air  under  diaphragm 
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                        RESULTS  AND  OBSERVATIONS 
A  prospective  study  for  determining  the  incidence  of  H  pylori  
in  a  perforated  duodenal  ulcer  is  carried  out.  The  following  
observations  are  made: 
The  mean  age  of  the  patient  is  44.6  yrs.  All  the  patients  are  
males.    83 %  are  smokers  (25  of  30  patients). 
5 (16.6%) were  addicted  to  pan  chewing  and  3 (10%)  were  in  
the  habit  of  gutkha  chewing.  17 (56.6%) of  30  patients  had  past  
history  of  pain  abdomen  more  in  the  epigastrium  relived  by  taking  
antacids / H2  blockers.  16  (53.3%) of  30  patients  had  history  of  
NSAIDS  abuse. Two  patients (6.6%) were  on  steroids. 
(53.3 %) 16 of  30  patients  whose  mucosal  biopsy  was  
subjected  to  rapid  urease  test  (RUT)  tested  positive  for  urease.  (10  
strongly  positive  and  6 moderately  positive) 
14 (46.7%)  of  tested  negative  for  RUT. 
16  of  the  30  patients  (53.3 %)  whose  mucosal  biopsy  was  
specially  investigated  for  H pylori  by  genta  tested  positive  for  the  
bacteria. 
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CHARTS 
MEAN AGE 
RUT + RUT  - 
44.6 42.4 
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Out of 30 patients in total: 
 H. PYLORI +ve H.PYLORI –ve 
Rapid Urease Test 16 14 
HPE 16 14 
Chi square -  0.5                         df - 1                          P < 0.05 
 
 
 
 
 
42.00%
44.00%
46.00%
48.00%
50.00%
52.00%
54.00%
RUT HPE
H.PYLORI+ve
H.PYLORI-ve
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Distribution in  Alcoholics: 
Alcohol RUT + RUT - 
+ ve 81.3 57.1 
-ve 18.7 42.9 
 
Chi square value df P 
2.1 1 0.2(not significant) 
 
 
 
73 
 
Distribution  in  Smokers: 
Smoking RUT + RUT - 
+ ve 87.5 78.6 
-ve 12.5 21.4 
 
Chi square value df P 
0.4 1 0.5(not significant) 
 
 
 
74 
 
Distribution  among  PAN  chewers: 
 
 
PAN RUT + RUT - 
+ ve 18.7 14.3 
-ve 81.3 85.7 
 
Chi square value df P 
0.4 1 0.7(not significant) 
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Distribution  in Ghutkha chewers: 
Guthka RUT + RUT - 
+ ve 6.2 14.3 
-ve 93.8 85.7 
 
Chi square value df P 
0.5 1 0.4 
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Distribution  of  APD: 
 
APD 
 
RUT + 
 
RUT - 
 
+ ve 
 
62.3 
 
64.3 
 
-ve 
 
37.7 
 
35.7 
 
Chi square value df P 
0.07 1 0.9(not significant) 
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Distribution  of  NSAIDs: 
NSAID RUT + RUT - 
+ ve 62.3 42.9 
-ve 37.7 57.1 
 
Chi square value df P 
1.2 1 0.3 
 
78 
 
 
Distribution  in  Antibiotic  users: 
 
 
 
ANTIBIOTIC RUT + RUT - 
+ ve 12.5 21.4 
-ve 87.5 78.6 
Chi square value df P 
0.4 1 0.5 
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Distribution  in  Steroid  Users: 
STEROIDS RUT + RUT - 
+ ve 6.2 7.1 
-ve 93.8 92.9 
 
Chi square value df P 
0.009 1 0.9 
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Distribution  of  Socioeconomic  status: 
SOCIO ECONOMIC STATUS RUT + RUT - 
L 43.8 57.1 
M 50 35.8 
H 6.2 7.1 
 
Chi square value df P 
0.5 1 0.4 
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                                           DISCUSSION 
This  is  a  prospective  study  of  thirty  cases  of  duodenal  ulcer  
perforation  admitted  to  Government  vellore  medical  college  &  
Hospital  during  the  period  August  2014   to  July – 2015  to  find  out  
association  of  H  pylori  in  the  case  of  duodenal  ulcer  perforation. 
The  aim  of  the  study  was  to  evaluate  the  incidence  of  
helicobacter  pylori  infection  in  perforated  duodenal  ulcer.  The  pylori  
infection  was  found  to  be  significantly  higher  in  the  younger  age  
group  with  male  preponderance  the  present  finding  correlates  with  
the  findings  of  M.Sebastin,  V.P.Permchand  etal. 
This  prospective  study  examined  a  pathological  etiological  
agent  namely  Helicobacter  pylori  in  perforated  duodenal  ulcer.  The  
high  incidence  of  H. pylori  infection  suggests  antibiotic  therapy  to  
eradicate  the  microorganism  should  be given  to  all  patients  with  
persisting  duodenal  ulcer. 
This  study  indicates  that  patients  with  perforated  ulcer  were  
infected  with  H. pylori  more  severly.  A  close  relationship  was  
observed  between  the  perforated  ulcer  and  density  of  H  pylori  our  
study  correlates  with  the  findings  of  yukihkotokunaga  etal. 
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Similar  studies  were  conducted  by 
1.Minmamli  N  Isforaand  et  al,  department  of  surgery  and  
pathology,  Sislietfal  training  hospital,  Istanbul  Turkey. 
In  the  study  conducted  by  dept  of  surgery,  Sisli  et al  
Hospital,  Istanbul,  Turkey,  patients  who  underwent  Surgery   for  a 
perforated  duodenal  ulcer  in  between  January  94  to  July  96  were  
studied.  The  study  population  consisted  of  18  patients  with  a  mean  
age  of  32.7  years.  (21  to  48  years).  Ulcer  was  excised  with  the  
pylori ring.  All  the  patients  were  treated  by  bilateral  truncal 
vagotomy  and  Weinberg  pyloroplasty.  Two  biopsies  were  taken  
from  the  antral  mucosa  by  endoscopic  biopsy  forceps.  The cut  was  
then  extended  by  about  2  cm  on  both  the  gastric  and  duodenal  
bulb.  The  defect  was  closed  transversely. 
The  ulcer  specimen  and  the  antral  biopsies  were  fixed  
separately  in  10 %  formalin  solution  and  sent  for  histopathology.  
Specimens  were  stained  with  H – E  stain  and  examined  for  H – 
pylori.  
H – pylori  was  found  in  the  antral  biopsies  of  16  patients  
(88.8 %)  and  in  (7)  of  the  ulcer  specimens  (38.8 %).  H – pylori  was  
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found  in the  mucosa  and  also  extended  through  the  wall  of  the  
ulcer.   H  pylori  was  present  at  a  high  ratio  in  the  antral  biopsies  
of  patients  with  duodenal  ulcer  perforation. 
In  our  series  a  combination  of  RUT  positivity  and  presence  
of  organism  on  Genta  staining  was  taken  as  positive  for  H  pylori. 
53.3  %  of  the  patients  tested  positive  for  RUT (10  of  
strongly positive,  6  moderately  positive) 
46.7 %  (14  of  30  patients) tested  negative  for  RUT. 
The  Istanbul  study  was  based  on  the  presence  of  H.pylori   in  
biopsy  specimens  stained  by  H – E  stain. 
In  our  study  all  the  cases  are  subjected  to  a  preliminary  
RUT,  whose  sensitivity  and  specificity  is  of  the  order  of  90 – 95 %.  
Later  all  the  biopsy  specimens  were  subjected  to  Genta  staining,  
which  is  a  much  more  better  staining  procedure  than  H – E  
staining,  used  in  Istanbul  study,   and  differs  from  H –E  staining,  in  
showing  the  mucosal  morphology,  but  also  stains  bacteria  which  are  
in  low  density,  in  a  small  biopsy  specimen,  and  in  presence  of  
abundant  debris  or  mucus  on  the  duodenal  surface 
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                        CONCLUSION 
Duodenal  ulcer  perforation  was  seen  in  the  age  group  of  25  
to  60  years  of  age  (mean  44.6  years) 
All  the  patients  are  males. 
Eighty three percent  (83%)  are  smokers. 
Seventy  threepercent (73.3%) are  chronic  alcoholics. 
Sixteen (16%)  percent  are  addicted  to  pan  chewing. 
Ten   percent (10%) are  addicted  to  gutkha  chewing. 
Sixty  three  percent (63.3%)  had  suffered  with  previous  history  
of  APD. 
Fifty three  percent(53.3%) had  the  history  of  NSAID  abuse. 
sixteen  percent(16.6%) were  under  Antibiotic  cover. 
Socio  enocomic  status  of  the  patients  were  considered  with  
High, Middle, low. 
High  group -  6.2%  RUT positive, 
Middle  group – 50%  RUT  positive 
Low  group  - 43.8%  RUT  positive 
Forty  five  percent  of  patients  were  in  treatment  for  APD. 
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  Most  of  the  patients  positive  on  rapid  urease  test  positivity  
were also found  positive  for  genta  staining. 
There  being  paucity  of  previous  pertaining  to  the  role  of  
H.Pylori  in  perforated  duodenal  ulcers  and  the  other  studies  like  
Istanbul  study  showing  as  association  of  H.Pylori  in  perforated  
duodenal  ulcer. 
However  our  study  showed  @ 53.3%  association  of  H. Pylori  
with  duodenal  ulcer  perforation  and  the  extensive  usage  of  
Antibiotics  and  liberal  utility  of  proton  pump  with  or  with  out   
combination  of  H2  receptor  blockers  shows  53.3%  positivity  and  
46.7%  negativity  with  the  incidence  of H. pylori  in  both  RUT  and  
HPE. 
The  incidence  of  Helicobacter  pylori  in  our  case  study  is  
about  53.3%.  Event though, the total  number  of  cases  are  less,  H. 
pylori  correlates  well with  the  cause  for  duodenal  ulcer  &  it  can  be  
considered  as  commonest  cause. Hence, Helicobacter  pylori  should  be  
eradicated  using  anti- H. pylori  regimen  in  all  cases  of  perforated  
duodenal  ulcer. 
The  number  of  cases  studied  and  the  various  entities  
considered  still  requires  further  studies  on  these  lines. 
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 PROFORMA: 
 
Name:       IP  No: 
Age:       SL   No: 
Sex:       Date  of  admission: 
Occupation:      Date  of  surgery: 
Religion:      Date  of  discharge: 
 
PRESENTING  COMPLAINTS 
Pain  Abdomen: 
Fever: 
Vomiting: 
Distension  of  Abdomen: 
Constipation: 
PAST  HISTORY 
Surgeries: 
Medical  conditions:  Diabetes / Hypertension / Tuberculosis / Asthma / Epilepsy 
FAMILY  HISTORY 
 PERSONAL  HISTORY 
Diet:      Sleep: 
Bowel / Bladder:   Smoker / Alcoholic: 
 
EXAMINATION 
GPE: 
Pallor:      Icterus: 
Cyanosis:     Clubbing: 
Lymphadenopathy: 
Vitals:  Pulse  rate: Blood   Pressure:                     RR:         
 
SYSTEMIC  EXAMINATION: 
Per  Abdomen: 
Cardiovascular  System: 
Respiratory  System: 
Central  Nervous  System: 
DIAGNOSIS: 
  
INVESTIGATIONS: 
Hb %:    TC:   DC:  ESR: 
 RBS: 
Blood  urea:  Serum  creatinine:  BT:  CT: 
X – ray  erect  abdomen:    ECG: 
USG  abdomen: 
HIV:       HBsAg: 
PREOPERATIVE  PREPARATION: 
NPO,   RTA,   Injection  TT, Injection  Xylo  test  dose,  IV  Antibiotics,   Preparing  
of  relevant  parts;  Informed  High  risk  consent 
PROCEDURE: 
Anesthesia:   Position:    
Exploratory  laprotomy  +  perforation  closure  +  grahams  patch: 
Postop:   Antibiotic:   Analgesic:  
COMPLICATIONS: 
FOLLOWUP: 
 
                               CERTIFICATE  OF  CONSENT 
I have  read  the  foregoing  information,  or  it  has  been  read  to  
me.  I  have  had  the  opportunity  to  ask  questions  about  it  and  any  
questions  that  I  have  asked  have  been  answered  to  my  satisfaction.  
I  consent  voluntarily  to  participate  as  a  participant  in  this  research  
and  understand  that  I  have  the  right  to  withdraw  from  the  research  
at  any  time  without  in  any  way  affecting  my  medical  care. 
Name  of  participant __________________________ 
Signature  of  Participant _______________________ 
Date _________________________ 
If  illiterate 
A  illiterate  witness  must  sign  ( if  possible,  this  person  should  be  
selected  by  the  participant  and  should  have  no  connection  to  the  
research  team). 
I  have  witnessed  the  accurate  reading  of  the  consent  from  to  the  
potential  participant,  and  the  individual  has  had  the  opportunity  to  
ask  questions.  I  confirm  that  the  individual  has  given  consent freely. 
Name  of  participant __________________________ 
Signature  of  Participant ________________________ 
Date _________________________      
            
 I  have   accurately  read  or  witnessed  the    accurate  reading  of  
the  consent  from  to  the  potential  participant,  and  the  individual  has  
had  the  opportunity  to  ask  questions.  I  confirm  that  the  individual  
has  given  consent freely. 
Name  of  participant __________________________ 
Signature  of  Participant ______________________  
Date ______________________ 
Thumb  print  of  participant 
 
 
 
 
A  copy  of  this  Informed  Consent  From  has  been  provided  to  
participant  _______________ ( initialed  by  the  researcher / assistant). 
 
 
 
 
 
 
 
 
  
  
  
  
  
  
 KEY  TO  MASTER  CHARTS: 
 
PA – PAIN  ABDOMEN 
FVCO  – FEVER  VOMITING,  CONSTIPATION / OLIGURIA 
ALCO  – ALCOHOL 
SMO  – SMOKING  
PAN  – PAN  CHEWER 
GUTK  – GUTKA  CHEWER 
T – TEMPERATURE 
PR  – PULSE  RATE 
UOP  – URINE  OUTPUT 
SES  – SOCIO  ECONOMIC  STATUS 
H / M / L – HIGH / MIDDLE / LOW 
RR  – RESPIRATORY  RATE 
RUT  – RAPID  UREASE  TEST 
HPE  – HISTOPATHOLOGICAL  EXAMINATION 
APD  – ACID  PEPTIC  DISORDER 
NSAID  – NONSTEROIDAL  ANTI  INFLAMMATORY  DRUGS 
ABIO  – ANTIBIOTICS 
STE  – STEROIDS 
PPI  – PROTON  PUMP  INHIBITORS 
H2  – H2  RECEPTOR  ANTAGONISTS 
Hb %  – HAEMOGLOBIN 
RBS  – RANDOM BLOOD SUGAR 
BU  – BLOOD  UREA 
 SC  – SERUM  CREATININE 
SAMY  – SERUM  AMYLASE 
Na +  – SODIUM 
K +  – POTASSIUM 
CL  – CHLORIDE 
XREA  –  X – RAY  ERECT  ABDOMEN 
USG   – ULTRASONOGRAPHY 
UGIE  – UPPER  GASTOINTESTINAL  ENDOSCOPY  
EL OPC     _     EMERGENCY  LAPROTOMY  &  LIVE  OMENTAL  PATCH   
                          CLOSURE 
 
 
 
S.No. NAME AGE / SEX IPCHIEF   COMPLAINTS RISK  FACTORS VITALS ASSOCIATED  FACTORS INVESTIGATIONS PROC POST OP
Abd pain fv co alc smo pan gutka T PR BP RR UO APD NSAID Ab Ster PPI H2b Hb RBS BU SC SAM Na K cl XRA SES RUT HPE
1 DINESH KUMAR 25/M 3214 (+ve) fv c (+ve) (+ve) (-ve) (-ve) high 102 118/68 30 1200 (+VE) (-VE) (-VE) (-VE) (-VE) (+VE) 13 112 26 0.8 70 140 4.5 102 (+VE) M (+VE) (+VE) EL OPC UNEVENT
2 SEKAR 40/M 3044 (+ve) fv c (+ve) (+ve) (-ve) (-ve) high 94 108/74 29 750 (+VE) (-VE) (+VE) (-VE) (+VE) (+VE) 12.6 120 30 1 48 138 3.8 112 (+VE) M (+VE) (+VE) EL OPC UNEVENT
3 VINOD KUMAR 30/M 3912 (+ve) fv c (-ve) (+ve) (-ve) (-ve) high 96 120/74 25 900 (+VE) (-VE) (-VE) (-VE) (+VE) (-VE) 14 135 28 0.9 89 142 4.3 104 (+VE) L (-VE) (-VE) EL OPC UNEVENT
4 CHINNAPAIYAN 67/M 3721 (+ve) fv co (+ve) (-ve) (-ve) (-ve) high 87 98/68 28 600 (-VE) (+VE) (-VE) (-VE) (-VE) (-VE) 10.8 80 48 1.4 145 130 2.8 94 (+VE) L (-VE) (-VE) EL OPC UNEVENT
5 CHIDAMBARAM 42/M 3954 (+ve) v c (+ve) (+ve) (-ve) (+ve) norm 112 104/64 20 450 (+VE) (-VE) (-VE) (+VE) (-VE) (+VE) 11.5 96 40 1.1 125 138 3.9 112 (+VE) L (+VE) (+VE) EL OPC UNEVENT
6 CHINNAKANNAN 60/M 4394 (+ve) fv c (+ve) (+ve) (+ve) (-ve) high 104 110/74 22 1300 (-VE) (+VE) (-VE) (-VE) (+VE) (+VE) 11 180 90 2.1 75 135 3 102 (+VE) L (-VE) (-VE) EL OPC UNEVENT
7 MANI 34/M 5664 (+ve) fv c (-ve) (+ve) (-ve) (-ve) high 98 100/60 28 450 (+VE) (-VE) (+VE) (-VE) (-VE) (-VE) 13.5 118 30 0.8 160 145 4.5 116 (+VE) M (-VE) (-VE) EL OPC UNEVENT
8 KUMAR 44/M 6478 (+ve) fv co (-ve) (+ve) (-ve) (-ve) high 122 90/? 45 NIL (+VE) (-VE) (-VE) (-VE) (-VE) (+VE) 12.5 75 60 1.9 49 125 2.9 96 (+VE) L (+VE) (+VE) EL OPC UNEVENT
9 KRISHNAN 50/M 6770 (+ve) v c (-ve) (-ve) (-ve) (-ve) norm 96 104/74 32 850 (+VE) (+VE) (-VE) (-VE) (+VE) (-VE) 11.8 130 50 1.4 68 135 3.8 102 (+VE) M (+VE) (+VE) EL OPC UNEVENT
10 SRINIVASAN 38/,M 6827 (+ve) fv co (+ve) (+ve) (+ve) (+ve) high 114 94/? 46 NIL (+VE) (-VE) (-VE) (+VE) (+VE) (-VE) 14 110 80 2.2 102 135 2.9 96 (+VE) L (+VE) (+VE) EL OPC UNEVENT
11 KUMARESAN 35/M 6976 (+ve) fv c (+ve) (+ve) (-ve) (-ve) high 80 120/84 30 1500 (+VE) (-VE) (-VE) (-VE) (-VE) (+VE) 10.2 98 36 1.1 - 140 3.9 114 (+VE) M (-VE) (-VE) EL OPC UNEVENT
12 ELUMAZHAI 62/M 8782 (+ve) v (+ve) (+ve) (+ve) (-ve) (-ve) norm 98 90/70 24 850 (+VE) (+VE) (-VE) (-VE) (-VE) (+VE) 9.8 85 52 1.5 60 136 3 110 (+VE) L (+VE) (+VE) EL OPC EXP
13 AKBAR SHARIF 27/M 9201 (+ve) v c (-ve) (+ve) (-ve) (-ve) norm 94 98/70 28 350 (+VE) (-VE) (+VE) (-VE) (+VE) (-VE) 14.2 128 28 0.9 170 142 4.3 108 (+VE) H (-VE) (-VE) EL OPC UNEVENT
14 SELVAM 55/M 9500 (+ve) fv co (+ve) (-ve) (-ve) (-ve) high 106 90/70 32 300 (-VE) (+VE) (-VE) (-VE) (-VE) (-VE) 11.8 95 52 1.4 50 135 3.2 102 (+VE) M (+VE) (+VE) EL OPC UNEVENT
15 SIVALINGAM 40/M 9681 (+ve) fv nil (+ve) (+ve) (-ve) (-ve) high 116 102/64 28 150 (-VE) (+VE) (-VE) (-VE) (+VE) (+VE) 12 110 40 1.2 89 138 3.9 104 (+VE) M (+VE) (+VE) EL OPC UNEVENT
16 UMAPATHY 63/M 10342 (+ve) fv co (+ve) (+ve) (+ve) (-ve) high 110 90/70 24 600 (-VE) (+VE) (-VE) (-VE) (-VE) (-VE) 9.6 110 90 2 61 130 2.8 96 (+VE) L (-VE) (-VE) EL OPC UNEVENT
17 MAHESH 22/M 11460 (+ve) fv c (-ve) (+ve) (-ve) (-ve) high 126 90/60 28 500 (+VE) (-VE) (-VE) (-VE) (+VE) (+VE) 14.2 126 28 1 132 142 4.5 102 (+VE) L (-VE) (-VE) EL OPC UNEVENT
18 PALANI 32/M 13247 (+ve) fv c (-ve) (-ve) (-ve) (-ve) high 106 100/60 22 800 (+VE) (-VE) (+VE) (-VE) (+VE) (+VE) 13 130 30 0.7 118 145 3.9 112 (+VE) L (+VE) (+VE) EL OPC UNEVENT
19 VENKATESAN 45/M 15734 (+ve) v c (+ve) (+ve) (-ve) (-ve) norm 85 110/72 20 1000 (+VE) (+VE) (-VE) (-VE) (+VE) (+VE) 11.8 180 32 0.9 - 150 4.5 108 (+VE) M (+VE) (+VE) EL OPC UNEVENT
20 PITCHANDI 43/M 17034 (+ve) v c (+ve) (+ve) (+ve) (-ve) high 95 120/76 35 1250 (-VE) (+VE) (-VE) (-VE) (-VE) (+VE) 12.5 108 50 1.3 98 136 4.1 112 (+VE) L (+VE) (+VE) EL OPC EXP
21 SARAVANAN 24/M 19359 (+ve) fv c (+ve) (+ve) (-ve) (-ve) high 98 94/74 40 750 (+VE) (-VE) (-VE) (-VE) (+VE) (-VE) 13.8 95 48 1.4 74 135 3.1 98 (+VE) H (-VE) (-VE) EL OPC UNEVENT
22 GUNASEKARAN 47/M 19806 (+ve) fv nil (+ve) (+ve) (-ve) (-ve) high 105 90/60 36 600 (+VE) (+VE) (-VE) (-VE) (-VE) (-VE) 12 86 50 1.8 80 130 2.6 94 (+VE) M (+VE) (+VE) EL OPC UNEVENT
23 DHANAJEYAN 40/M 26171 (+ve) fv co (+ve) (+ve) (-ve) (-ve) high 90 108/78 30 1300 (+VE) (+VE) (-VE) (-VE) (+VE) (+VE) 11.2 130 30 1 - 140 4.2 100 (+VE) L (-VE) (-VE) EL OPC UNEVENT
24 MUNUSAMY 47/M 27179 (+ve) fv c (+ve) (+ve) (-ve) (-ve) high 98 120/76 26 1100 (+VE) (+VE) (-VE) (-VE) (-VE) (-VE) 13.2 125 20 0.5 152 138 4.5 116 (+VE) M (+VE) (+VE) EL OPO UNEVENT
25 SUNDAR 28/M 27735 (+ve) fv c (-ve) (-ve) (-ve) (-ve) high 104 100/60 36 500 (-VE) (-VE) (+VE) (-VE) (+VE) (+VE) 14.8 112 48 1.4 139 128 3 98 (+VE) L (-VE) (-VE) EL OPC UNEVENT
26 RAMARAJ 39/M 28441 (+ve) v c (+ve) (+ve) (+ve) (-ve) norm 84 130/80 20 1200 (-VE) (+VE) (-VE) (-VE) (+VE) (-VE) 11.5 118 28 0.9 79 138 4.2 108 (+VE) H (+VE) (+VE) EL OPC UNEVENT
27 PARASURAMAN 53/M 31176 (+ve) fv co (+ve) (+ve) (-ve) (-ve) high 102 104/68 32 800 (-VE) (+VE) (-VE) (-VE) (-VE) (+VE) 12.8 130 35 0.7 90 145 4 112 (+VE) M (-VE) (-VE) EL OPC UNEVENT
28 GOPAL 65/M 31644 (+ve) fv co (+ve) (+ve) (-ve) (-ve) high 110 94/74 38 700 (-VE) (+VE) (-VE) (-VE) (-VE) (+VE) 10.8 108 40 0.9 94 135 3.9 114 (+VE) L (-VE) (-VE) EL OPC EXP
29 SUBRAMANI 46/M 32982 (+ve) fv c (+ve) (+ve) (-ve) (-ve) high 98 110/74 30 600 (+VE) (-VE) (-VE) (-VE) (+VE) (-VE) 14.2 140 50 1.4 88 130 2.8 94 (+VE) M (-VE) (-VE) EL OPC UNEVENT
30 DHARMAN 65/M 3933 (+ve) FV CO (+ve) (+ve) (-ve) (-ve) norm 88 110/70 35 800 (-VE) (+VE) (-VE) (-VE) (+VE) (+VE) 11.2 150 48 1.3 70 130 3 94 (+VE) L (+VE) (+VE) EL OPC UNEVENT
